Kim, Jeonghwan http://orcid.org/0000-0002-1697-5107
Eygeris, Yulia
Ryals, Renee C.
Jozić, Antony http://orcid.org/0000-0001-6249-2328
Sahay, Gaurav http://orcid.org/0000-0003-1071-0500
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL146736-01)
Cystic Fibrosis Foundation (SAHAY 19XX0)
U.S. Department of Health & Human Services | NIH | National Eye Institute (1R01EY033423-01A1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R01CA270783-01)
Article History
Received: 16 April 2023
Accepted: 1 November 2023
First Online: 27 December 2023
Competing interests
: G.S. serves as an advisor to Rare Air Inc and RNAvax Bio. G.S. is a co-founder of EnterX Bio and Y.E. has stock options and an advisory role with EnterX Bio. EnterX Bio has a scientific research agreement with OSU. G.S. has a conflict management plan at OSU. The other authors declare no competing interests.